OTC Leadership Hypera's dominant consumer health portfolio with iconic brands enables exclusive distribution and co-branded campaigns with major pharmacy chains, plus cross-sell opportunities across prescription, dermocosmetics and generics to maximize shelf impact.

Institutional Growth Expansion into the institutional market opens opportunities to win hospital and clinic formulary contracts, implement volume-based sourcing, and explore private-label partnerships with health systems in Brazil and adjacent markets.

ESG Advantage Membership in the ESG index signals strong governance and sustainable practices that can help win ESG-focused tenders and attract distributors who prioritize responsible sourcing and packaging.

Manufacturing Capacity A diversified product portfolio and scale create potential for toll manufacturing, contract manufacturing, or private-label partnerships for other brands or entering new regional markets.

Digital Readiness An active digital footprint and data-driven marketing capabilities present opportunities for digital patient engagement campaigns, e-commerce optimization, and sales enablement for Hypera's consumer health brands.